logo

For the Inventor, By the Inventor

Suita, Japan

Takahito Kitayoshi

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited. Active years: 2000-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahito Kitayoshi. Retrieved from https://idiyas.com/inventor/takahito-kitayoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Osaka, JP (2000 - 2002)
  • Suita, JP (2000 - 2005)

Company Filing History:

goldMedal5 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
silverMedal1 out of 1,226 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2000-2005

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6852743 - Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof (2005-02-08),
2. 6833381 - TNF-&agr; inhibitors (2004-12-21),
3. 6413947 - Anilide derivative, production and use thereof (2002-07-02),
4. 6166006 - Anilide derivative, production and use thereof (2000-12-25),
5. 616600 - Anilide derivative, production and use thereof (2000-12-26),
6. 6133502 - Monocyte chemoattractant protein and its receptor transgenic animal (2000-10-17),

Title: The Innovations of Takahito Kitayoshi

Introduction

Takahito Kitayoshi is a prominent inventor based in Suita, Japan. He has made significant contributions to the field of medical science, particularly in the area of cerebrovascular disorders. With a total of six patents to his name, Kitayoshi's work has the potential to impact many lives.

Latest Patents

Among his latest patents are innovative agents designed to prevent the recurrence of cerebrovascular failure and to ameliorate troubles following such failures. These agents contain compounds with angiotensin II antagonistic activity, which are crucial for preventing cerebrovascular disorders and inhibiting their progression. Additionally, he has developed TNF-α inhibitors that include heterocyclic compounds with similar antagonistic activity, proving useful in treating inflammatory diseases.

Career Highlights

Throughout his career, Takahito Kitayoshi has worked with notable companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in pharmaceuticals.

Collaborations

Kitayoshi has collaborated with esteemed colleagues, including Mitsuru Shiraishi and Yoshio Aramaki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Takahito Kitayoshi's contributions to medical science through his patents and collaborations highlight his dedication to improving health outcomes. His work continues to pave the way for advancements in the treatment of cerebrovascular disorders and inflammatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…